Decoding the significance of subnormal liver enzyme activity

FHS
July 3, 2024
5:10 am

Liver diseases are commonly diagnosed using serum enzyme assays, particularly for aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), and 5′-nucleotidase (5′-NT).

Blood-brain barrier model may lead to prevention of meningitis in newborns

Investigators in Israel and Italy have developed a model of the blood-brain barrier, studies of which may lead to prevention of meningitis in newborns.

June 22, 2023

Poseida shares incremental Phase 1 update for Roche-partnered off-the-shelf CAR-T

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 1, 2024

Gilead pays $43M to license Xilio’s IL-12 program that could turn ‘cold’ tumors ‘hot’

Xilio Therapeutics had a bevy of announcements on Thursday — it entered a licensing deal for its Phase 1 IL-12 program with Gilead, took an

March 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.